HC Wainwright holds $40 target on Immunome
HC Wainwright kept its $40 price target for Immunome, Inc. (NASDAQ:IMNM) steady and noted the company granted inducement options for 86,500 shares to four new hires at a $27.07 exercise price with four-year vesting.